Clinical Trials Sponsored by Serpin Pharma, LLC

Total 367 results

Serpin Pharma, LLC
University of Virginia

Recruiting

SP16 as a Therapeutic for COVID-19 Induced ARDS

Pneumonia | SARS CoV 2 Infection

United States
Serpin Pharma, LLC
Virginia Commonwealth University

Completed

SP16 Inflammatory Response Inhibition Trial (SPIRIT)

Myocardial Infarction | Inflammation

United States
Serpin Pharma, LLC
Virginia Commonwealth University; George Mason University

Completed

SP16 SERPIN-like Peptide Administration in Healthy Individuals

Healthy Participants

United States
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
1200 Pharma, LLC

Terminated

First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors

Advanced Solid Tumor

United States
Valinor Pharma LLC

Active, not recruiting

Naloxegol US PMR CV Safety.

Opioid Induced Constipation

United States
PRM Pharma, LLC

Withdrawn

Effect of PRM-125 on Ambulatory Blood Pressure

Hypertension

United States
BHR Pharma, LLC

Terminated

Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue (4WARD)

Mammographic Breast Density

United States, Germany, Spain
Woerwag Pharma LLC

Completed

Milgamma® and Milgamma® Compositum Step-therapy in Patients With Acute Non-specific Low Back Pain Receiving Modern NSAID

Acute Non-specific Low Back Pain

Russian Federation
TesoRx Pharma, LLC

Terminated

A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males

Endocrine System Diseases | Gonadal Disorders | Hypogonadism | Hypogonadism, Male | Testosterone Deficiency

United States
TesoRx Pharma, LLC

Completed

Oral Testosterone for the Treatment of Hypogonadism in Males

Hypogonadism

United States
Midnight Pharma, LLC

Completed

Study to Evaluate the Relative Abuse Potential of Almorexant in Recreational Drug Users

Abuse Potential Study
Promius Pharma, LLC

Terminated

Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails

Onychomycosis

United States, Dominican Republic
Synerx Pharma, LLC

Completed

Comparative Bioavailability Study of Synerx and Verelan PM 300 mg Verapamil HCl ER Capsules Under Fed Conditions

Healthy
CereMark Pharma, LLC

Not yet recruiting

Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease

Alzheimer Disease | Chronic Traumatic Encephalopathy
CinPhloro Pharma, LLC

Recruiting

Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

Irritable Bowel Syndrome With Diarrhea

United States
Promius Pharma, LLC

Completed

Eight Week Study of Treatment With DFD-07 for Actinic Keratosis of the Face and Scalp

Actinic Keratosis

Germany
Promius Pharma, LLC

Completed

Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis

Atopic Dermatitis

United States
Midnight Pharma, LLC

Completed

Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia (RESTORA 1)

Primary Insomnia

Spain, Germany, Belgium, France, United Kingdom, Australia, Austria, Bulgaria, Czech Republic, Denmark, Finland, Hungary, Israel, Italy, Poland, Slovakia, South Africa, Sweden, Switzerland, Ukraine
TesoRx Pharma, LLC

Completed

Oral Testosterone for the Treatment of Hypogonadism

Hypogonadism

United States
Promius Pharma, LLC

Completed

Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis

Psoriasis

United States
RFS Pharma, LLC

Withdrawn

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects

Human Immunodeficiency Virus Infection
Fulgent Pharma LLC.

Recruiting

FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

Head and Neck Squamous Cell Carcinoma

United States
BHR Pharma, LLC

Terminated

Study of Progesterone in Treatment of Vasomotor Symptoms (PROGEST)

Menopause Related Conditions

Germany
Promius Pharma, LLC

Completed

DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis (HPA axis)

Psoriasis

United States
Promius Pharma, LLC

Completed

A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

Psoriasis

United States
Promius Pharma, LLC

Completed

A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis

Chronic Stable Plaque Psoriasis

United States
Promius Pharma, LLC

Completed

Promiseb Topical Cream for Cradle Cap

Cradle Cap | Infantile Seborrheic Dermatitis

United States
Midnight Pharma, LLC

Completed

Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia

Chronic Primary Insomnia

United States
Promius Pharma, LLC

Completed

ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis

Actinic Keratosis

United States
Midnight Pharma, LLC

Completed

Almorexant in Primary Insomnia (Insomnia)

Insomnia | Primary Insomnia

Austria, Denmark, Finland, Germany, Israel, Netherlands, Spain, Sweden, Switzerland, United Kingdom
RFS Pharma, LLC

Terminated

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.

Human Immunodeficiency Virus Infection

Argentina
Promius Pharma, LLC

Terminated

Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails

Onychomycosis

United States
ActivBiotics Pharma, LLC

Completed

Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women

Chlamydia Trachomatis Infection

United States
RFS Pharma, LLC

Completed

Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV

HIV Infections

Argentina
Redx Pharma Plc
Merck Sharp & Dohme LLC

Completed

A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2) (KEYNOTE-E86)

Advanced Solid Tumours

United Kingdom, Australia
4D pharma plc
Merck Sharp & Dohme LLC

Terminated

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

Melanoma | Renal Cell Carcinoma | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Oncology

United States
Acerta Pharma BV
Acerta Pharma, LLC

Completed

An Open-Label, Phase 1b Study of Acalabrutinib With and Without Dexamethasone in Subjects With Multiple Myeloma

Multiple Myeloma (MM)

United States, United Kingdom
R-Pharm Overseas, Inc.
R-Pharm; Data Management 365; Cromos Pharma LLC; Keystat, LLC; K-Research

Completed

Study to Evaluate the Effect on Parameters of Systemic Inflammation and Disease Outcomes and Safety of RPH-104 in Subjects With Acute ST-elevation Myocardial Infarction

Acute ST Segment Elevation Myocardial Infarction

United States, Russian Federation
Lipac Oncology LLC
TesoRx Pharma, LLC

Completed

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

Urologic Neoplasms | Urogenital Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Neoplasms | Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Non-Muscle Invasive Bladder Cancer | Urinary Bladder | Bladder Cancer Cell Transitional

United States
Fertin Pharma A/S

Completed

Single-Dose Bioequivalence Study Comparing Two 2 mg Nicotine Lozenges

Smoking Cessation

South Africa
Fertin Pharma A/S

Completed

Single-Dose Bioequivalence Study Comparing Two 4 mg Nicotine Lozenges

Smoking Cessation

South Africa
Fertin Pharma A/S

Completed

Comparison of Pharmacokinetic Profiles of 3 New Nicotine Gum Formulations With a Reference Gum

Smoking Cessation
Aphaia Pharma US LLC

Recruiting

A Study to Evaluate Efficacy and Safety of Distal Jejunal-release Dextrose Beads Formulation (APHD-012) in Subjects With a Pathological Oral Glucose Tolerance Test (OGTT)

PreDiabetes | Glucose Tolerance Impaired

Slovakia
Aphaia Pharma US LLC

Recruiting

A Study of Distal Jejunal-release Dextrose in Obese Participants

Obese

Germany, Puerto Rico
Exela Pharma Sciences, LLC.

Terminated

Efficacy and Safety of Tranexamic Acid in Spinal Fusion Surgery

Spinal Fusion

United States
Exela Pharma Sciences, LLC.

Completed

Comparative Efficacy and Safety of Ciprofloxacin 0.3% and Dexamethasone 0.1% in Acute Otitis Externa

Acute Otitis Externa

United States, Puerto Rico
AstraZeneca
Acerta Pharma, LLC

Completed

A Study to Evaluate Relative Bioavailability, Proton Pump Inhibitor (PPI) (Rabeprazole) Effect, Food Effect and Particle Size Effect of New Acalabrutinib Tablet in Healthy Subjects

Bioavailability | B-cell Lymphoid Cancer

United States
Bioniche Pharma USA LLC

Completed

Bioequivalence Study of Azacitidine for Injection in Myelodysplastic Syndrome (MDS) Patients

Myelodysplastic Syndrome

United States, France

3

Subscribe